Work

Since the Inflation Reduction Act (IRA) was passed in 2022, significant discussion has been devoted to its potential consequences for the development of new drugs. This report examines whether the IRA has had immediate impacts on drug development in the first half of 2023 through analysis of the companies’ R&D investments and M&A and licensing activities.

Since 2019, ATI Advisory and the Long-Term Quality Alliance, with support from The SCAN Foundation, have led national efforts to advance person-centered, non-medical supplemental benefits in Medicare Advantage.

Beneficiaries who are Black or Latino/a are more likely than white beneficiaries to report difficulty with activities of daily living (ADLs) and other conditions that can negatively impact their health. Understanding the experiences of individuals reporting difficulty with ADLs across race and ethnicity can help policymakers develop strategies to address inequities. This databook, supported by the Robert Wood Johnson Foundation, conveys research findings on the racial and ethnic disparities among this population across social determinants of health, natural community supports, and health care experiences.

Beneficiaries who are Black or Latino/a are more likely than white beneficiaries to report difficulty with activities of daily living (ADLs) and other conditions that can negatively impact their health. Understanding the experiences of individuals reporting difficulty with ADLs across race and ethnicity can help policymakers develop strategies to address inequities. This databook, supported by the Robert Wood Johnson Foundation, conveys research findings on the racial and ethnic disparities among this population across social determinants of health, natural community supports, and health care experiences.

ATI Advisory in partnership with the Rosalynn Carter Institute for Caregivers (RCI) sought to explore the evidence and needs of dementia caregivers that might inform a Medicare model test related to dementia care. On July 31, 2023, the Center for Medicare and Medicaid Innovation (CMMI) released the Guiding an Improved Dementia Experience (GUIDE) Model that includes explicit support for caregivers and is set to launch in July 2024.

An analysis of nonmedical supplemental benefit offerings in metro and non-metro areas found that 42% of metropolitan MA plans offer these benefits compared to 34% of rural MA plans. While the presence of benefits does not equate to access, this databook points to the need for additional research on utilization of benefits to examine any issues with equitable access across metro and non-metro counties.